The Medicines Company

December 10, 2009 – European approval was recently granted for the use of Angiox (bivalirudin) as an anti-coagulant in ...

December 10, 2009

November 18, 2009 — A new, reversible blood thinner did not prove superior over placebo for its primary endpoints of ...

November 20, 2009

October 17, 2008 - The Medicines Company’s Angiomax (bivalirudin) significantly reduced cardiac-related death, improved ...

October 16, 2008

May 27, 2008 - Angiomax (bivalirudin) significantly improved net clinical adverse events by 24 percent as well as ...

May 26, 2008

January 29, 2008 - The Medicines Company received the European Commissionï¿½s authorization of an expanded use for ...

January 28, 2008

September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application ...

September 24, 2007

Related Content